Pharmaceutical Technology

MARCH 14, 2023

Platinum-based cancer drug compositions is a key innovation area in chemotherapy Platinum-based drugs are chemotherapeutic agents used for the treatment of cancer. These compounds cause their therapeutic effect by inhibiting DNA synthesis.

Chemotherapy 52

Chemotherapy Mayo Clinic Compounding Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 14, 2023

Purine derivatives-based cancer drug compositions is a key innovation area in chemotherapy Purine is an important heterocyclic nucleus in the chemical architecture of many bioactive compounds. Among its key functions, it interacts with nucleic acids and enzymes during their synthesis and function.

Chemotherapy 52

Chemotherapy Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

SEPTEMBER 19, 2023

Venus Remedies has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs. billion by 2029 at a compounded annual growth rate (CAGR) of 8.2 With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles. per cent from 2021 to 2030.

Chemotherapy 97

Chemotherapy Compounding 97

European Pharmaceutical Review

DECEMBER 5, 2022

The PSMAfore results are the second positive set of data for Pluvicto in a Phase III trial, after the VISION clinical trial, where PSMA–positive mCRPC patients who received Pluvicto plus standard of care (SoC) after ARPI and taxane-based chemotherapy, showed statistically significant reduction in risk of death. The PSMAfore study.

Chemotherapy 95

Chemotherapy Compounding Labelling Drug Development 95

Pharmaceutical Technology

APRIL 4, 2023

Ivospemin is a subcutaneously administered polyamine analogue being developed by Panbela to induce polyamine metabolic inhibition (PMI) through the exploitation of an observed high affinity of the compound for pancreatic ductal adenocarcinoma and other tumours.

Chemotherapy 59

Chemotherapy Compounding 59

European Pharmaceutical Review

OCTOBER 17, 2022

Pluvicto combines a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope (in this case lutetium-177). Pluvicto delivers radiation to PSMA-positive cells and the surrounding microenvironment. A Phase III trial showed Pluvicto improved survival for patients with pre-treated PSMA-positive mCRPC.

Chemotherapy 118

Chemotherapy Compounding 118

Pharmaceutical Technology

APRIL 24, 2023

Aspirin is a famous example, and originated from salicin, a compound in willow tree bark, with some still using pieces of willow bark as an alternative herbal medicine. In the past few decades, a compound from the dye indirubin has been shown to display early clinical effectiveness as an anti-cancer drug.

Compounding 105

Compounding Chemotherapy 105

Pulses

APRIL 27, 2023

When I discovered an interest in non-sterile compounding during my first year of pharmacy school, I worked with a professor to create and deliver content. I also had the opportunity to educate younger students by creating an activity for a third-year compounding elective. Is peer- and near-peer teaching effective?

Compounding 95

Compounding Sterile Compounds Communication Chemotherapy 95

National Association of Boards of Pharmacy

DECEMBER 13, 2023

Many other drugs have appeared on FDA’s shortage list in the past few years, including ADHD medications, chemotherapy treatments, and even antibiotics. Simultaneously, compounding pharmacies have been overwhelmed with the production of semaglutide injections that are compounded copies of Ozempic and Wegovy.

Diabetes 56

Diabetes Compounding Pharmacies Compounding Online Pharmacies 56

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. Benefits of daily oral chemotherapy over IV.

Chemotherapy 83

Chemotherapy Dosage Labelling Compounding 83

epicur

SEPTEMBER 13, 2023

However, the more closely we look at what it takes to compound an exact strength, the clearer it becomes standard dosages are more beneficial to both patients and veterinary practices. Exact strengths are compounded by a technician in capsules or tablets at traditional 503A pharmacies. milligram tablet and a 1.6 milligram tablet.

Dosage 52

Dosage Compounding Compounding Pharmacies Labelling 52

European Pharmaceutical Review

AUGUST 17, 2022

Radioligand therapy (RLT), which combines a targeting compound (ligand) with a therapeutic radioactive atom (radioisotope), is an emerging treatment approach that may offer an alternative treatment option for some cancer patients. Its licensing makes it the first diagnostic PSMA imaging tracer to receive this status in Great Britain.

Chemotherapy 111

Chemotherapy Labelling Compounding 111

Pharmaceutical Technology

MARCH 23, 2023

The drug is currently licensed in combination with chemotherapy for patients with classical Hodgkin lymphoma, both as frontline therapy and for those at risk of progressing or having progressed following stem cell transplantation. compound annual growth rate (CAGR) according to Pfizer’s risk-adjusted projection.

Chemotherapy 59

Chemotherapy Compounding 59

Express Pharma

APRIL 3, 2023

The diagnosed prevalent cases of gastric, breast, and bladder cancers in China are expected to increase at a compound annual growth rate (CAGR) of 2.6 per cent, 1.6 per cent, and 3 per cent, respectively, between 2022 and 2028. Specifically, the number of cases of gastric cancer is expected to rise from 946,090 to 1.1

Chemotherapy 81

Chemotherapy Compounding Drug Development 81

pharmaphorum

DECEMBER 5, 2022

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

Chemotherapy 57

Chemotherapy Compounding Labelling Drug Development 57

Pharmaceutical Technology

MAY 12, 2023

The agent is a human epidermal growth factor receptor 2 (HER2)-targeting ADC that utilises Eisai’s chemotherapy Halaven (eribulin) as its payload. GlobalData analyst consensus forecasts project sales to reach $11.5bn by 2029, a 29% compound annual growth rate (CAGR). targeting ADC.

Chemotherapy 64

Chemotherapy Compounding 64

Pharmaceutical Technology

FEBRUARY 24, 2023

ACD-440 overview ACD-440 is under development for the treatment of neuropathic pain including painful peripheral polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia (PHN), chemotherapy induced neuropathic pain, nerve injury pain, chronic postoperative neuropathic pain and peripheral neuropathic pain.

Chemotherapy 40

Chemotherapy Compounding Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

JUNE 27, 2022

The transaction is focused on Epizyme’s lead asset, Tazverik (tazemetostat), a chemotherapy-free EZH2 a inhibitor. Furthermore, we are excited to bring on board epigenetic expertise and the SETD2 inhibitor, as well as several pre-clinical compounds into our portfolio.”. for each share.

Chemotherapy 59

Chemotherapy Compounding 59

pharmaphorum

APRIL 20, 2021

One of the filings is to convert the ADC’s current conditional approval as a later-line therapy for urothelial cancer in patients previously treated with PD-1/L1 checkpoint inhibitors and platinum-based chemotherapy into a full approval. Both have been granted an FDA priority review with an action date of 17 August.

Chemotherapy 52

Chemotherapy Compounding Labelling 52

Pharmaceutical Technology

JUNE 27, 2022

The alliance will also focus on potential combinations with other agents, including immunotherapies, chemotherapy, as well as other targeted agents. Elzovantinib (TPX-0022) is presently being studied in Phase I of SHIELD-1 trial on patients diagnosed with advanced solid tumours and indicating genetic changes in MET.

Chemotherapy 59

Chemotherapy Compounding 59

epicur

JANUARY 30, 2023

That’s really going to be where learning more about compounding is for me—for example, differentiating the usage between 3% eyedrops vs. 2% or 1%. For example, I find all of the chemotherapy drugs Epicur has so neat, because they are such incredible products for the veterinary health industry and not many people are talking about them.

Compounding 52

Compounding Dosage Chemotherapy Communication 52

pharmaphorum

AUGUST 5, 2021

The interface is highly hydrophobic, hence any compounds containing water would be repelled. It is a popular method in systems biology, requiring fewer compounds to be screened in bioassays, reducing time and cost. The surface of PPIs, known as the interface, is typically flat with a limited number of grooves.

Compounding 125

Compounding Chemotherapy Drug Development 125

pharmaphorum

FEBRUARY 24, 2021

That compound (previously called TAK-580) was taken into a phase 1/2b trial in children with the brain cancer glioma before the Japanese drugmaker returned the rights after a review of its pipeline assets. The agreement is the second licensing deal for Day One that targets the MAPK pathway, which is implicated in a wide range of tumours.

Chemotherapy 71

Chemotherapy Compounding 71

pharmaphorum

FEBRUARY 4, 2021

On 4 February NICE announced it will back regular NHS funding England and Wales for Merck, Sharp and Dohme’s Keytruda in combination with pemetrexed and platinum chemotherapy in certain lung cancer patients. MSD will continue to work with the NHS looking at how the lung cancer pathway can be improved.

Chemotherapy 133

Chemotherapy Compounding 133

pharmaphorum

DECEMBER 23, 2020

While Trodelvy is already conditionally approved in the US, the data showing the drug improved overall survival compared with chemotherapy could be enough for it to clinch a permanent licence in the US. months in patients treated with chemotherapy. In the 500 patient trial, patients treated with Trodelvy lived for a median of 12.1

Chemotherapy 81

Chemotherapy Compounding Vaccines 81

RX Note

JUNE 3, 2023

Who are allowed to dispense or compound any poison for use in medical treatment? Good Compounding Practice Good Manufacturing Practice PIC/S Guidelines Briefly explain basic principles of compounding. In the absence of stability data, how long is the duration before the compounded preparations need to be discarded?

Health and Personal Care Stores 40

Health and Personal Care Stores Chemotherapy Compounding Dosage 40

Pharmaceutical Technology

MARCH 23, 2023

It is also being assessed in other tumour types and along with other Incyte pipeline compounds. Zynyz monotherapy showed a 52% objective response rate (ORR) in chemotherapy-naïve patients. We continue to study the potential of Zynyz in additional tumour types and in combination with other Incyte pipeline compounds.”

Adverse Reactions 98

Adverse Reactions Compounding Chemotherapy Labelling 98

RX Note

AUGUST 4, 2023

You may also refresh knowledge of clinical pharmacokinetics , total parenteral nutrition or chemotherapy before entering the relevant rotations. You should be at least familiar with insulin and inhalers counselling before entering ward, inpatient or outpatient. What to do if I did not know the answer to questions from patients or doctors?

Hospitals 52

Hospitals Inpatient Community Pharmacies Dosage 52

European Pharmaceutical Review

OCTOBER 19, 2023

With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? What do you envision the future of radiopharmaceuticals to be like?

Chemotherapy 88

Chemotherapy Compounding Immunity Immunization 88

RX Note

JUNE 5, 2023

Workplace activity involves how healthcare workers use and handle the drug in the workplace - such as opening shipments, compounding, administering or cleaning up after use or spills. Oral hazardous drugs No crushing or compounding may be done in an unprotected environment.

Compounding 52

Compounding Packaging Hospitals Chemotherapy 52

FDA Law Blog: Biosimilars

JANUARY 18, 2024

whether growing or not; its seeds; resin extracted from any part; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. chemotherapy-induced), pain, and post-traumatic stress disorder. chemotherapy-induced), and pain. chemotherapy-induced), and pain. 21 U.S.C. §

Controlled Substances 69

Controlled Substances Chemotherapy Compounding Dosage 69

pharmaphorum

SEPTEMBER 21, 2022

Enter Puma Biotech, which is paying a modest $7 million upfront for rights to alisertib (formerly MLN8237) and plans to run clinical trials of the compound in breast and lung cancers. Takeda is also in line for just over $287 million in potential milestone payments, plus royalties on net sales if it reaches the market.

Chemotherapy 62

Chemotherapy Compounding 62

The Thyroid Pharmacist

SEPTEMBER 1, 2023

The fluorine anion (negatively charged ion), or any of the compounds containing the anion, are termed fluorides. In pure form, it is a highly-toxic, yellowish-green gas.

Adverse Reactions 115

Adverse Reactions Compounding Chemotherapy Labelling 115

European Pharmaceutical Review

JANUARY 3, 2023

Cisplatin and other platinum-based compounds are essential chemotherapeutic agents for many cancers, yet they can cause ototoxicity, permanent and irreversible hearing loss, which occurs in up to 50-60 percent of adult patients and 90 percent of paediatric patients who survive cancer. This control arm will provide natural history data.

Chemotherapy 52

Chemotherapy Compounding 52

Express Pharma

MARCH 24, 2023

Ivospemin (SBP-101) Ivospemin is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma and other tumors.

Chemotherapy 71

Chemotherapy Compounding Diabetes 71

Pharmaceutical Technology

AUGUST 12, 2022

By 2028, the market is expected to reach $25 billion, with a compound annual growth rate (CAGR) of 46.6%. The standard first-line treatment for DLBCL is a chemotherapy regimen, alongside the monoclonal antibody rituximab. Overall, the global CAR-T cell market for all indications was worth $1.7 billion by the end of 2022.

Immunity 52

Immunity Immunization Chemotherapy Compounding 52

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. Faslodex will be administered in the control arm of the Phase III study, allowing for direct comparison between the two ER degraders.

Dosage 59

Dosage Chemotherapy Compounding Immunity 59